The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
Open accessAbstract
Significance: The NLRP3 inflammasome is an intracellular oligomer regulating the activation of caspase-1 for the processing and secretion of IL-1β and IL-18. Although there is growing evidence to substantiate inflammasome inhibition as a therapeutic option for the treatment of inflammatory diseases, to date, there are no approved humans agents. OLT1177, a β-sulfonyl nitrile molecule, shown to be safe in humans, is a selective inhibitor of the NLRP3 inflammasome, with unique properties to reverse the metabolic costs of inflammation and to treat IL-1β– and IL-18–mediated diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066 · cited 1×
“Activation of caspase-1 takes place by the oligomerization of intracellular proteins, termed inflammasomes, which induce the autocatalytic activation of caspase-1 (2, 3).”
BackgroundSuccinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176 · cited 1×
“Indeed, succinate levels correlate with the stabilization of HIF-1 α and the induction of proinflammatory cascades leading to the accumulation and release of IL-1 β (44).”
BackgroundNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Inflammasomes: mechanism of action, role in disease, and therapeutics
Guo, H., Callaway, J. B., & Ting, J. P.-Y. (2015) · Nature Medicine · doi:10.1038/nm.3893 · Cited by 3,340
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Coll, R. C., Robertson, A. A. B., Chae, J. J., Higgins, S. C., Muñoz-Planillo, R., Inserra, M. C., Vetter, I., Dungan, L. S., Monks, B. G., Stutz, A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3806 · Cited by 2,849
Inflammatory caspases are innate immune receptors for intracellular LPS
Shi, J., Zhao, Y., Wang, Y., Gao, W., Ding, J., Li, P., Hu, L., & Shao, F. (2014) · Nature · doi:10.1038/nature13683 · Cited by 2,285
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Youm, Y.-H., Nguyen, K. Y., Grant, R. W., Goldberg, E. L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3804 · Cited by 2,172
Muñoz-Planillo, R., Kuffa, P., Martínez-Colón, G., Smith, B. L., Rajendiran, T. M., & Núñez, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.016 · Cited by 2,147
Franchi, L., Eigenbrod, T., Muñoz-Planillo, R., & Nuñez, G. (2009) · Nature Immunology · doi:10.1038/ni.1703 · Cited by 1,834
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Self-citationMetabolic Pathways in Immune Cell Activation and Quiescence
Pearce, E. L., & Pearce, E. J. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.005 · Cited by 1,692 · cited 1×
“Proinflammatory stimuli, i.e., LPS, activate macrophages and dendritic cells, driving systemic and tissue metabolic reprogramming similar to that of the Warburg effect (22, 40, 41).”
BackgroundHoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A., & Kolodner, R. D. (2001) · Nature Genetics · doi:10.1038/ng756 · Cited by 1,682
Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activation
Krawczyk, C. M., Holowka, T., Sun, J., Blagih, J., Amiel, E., DeBerardinis, R. J., Cross, J. R., Jung, E., Thompson, C. B., Jones, R. G., et al. (2010) · Blood · doi:10.1182/blood-2009-10-249540 · Cited by 1,246
Everts, B., Amiel, E., Huang, S. C.-C., Smith, A. M., Chang, C.-H., Lam, W. Y., Redmann, V., Freitas, T. C., Blagih, J., van der Windt, G. J. W., et al. (2014) · Nature Immunology · doi:10.1038/ni.2833 · Cited by 1,064
Interleukin-18 and IL-18 Binding Protein
Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00289 · Cited by 938 · cited 1×
“Preclinical studies reveal that IL-18 is a target in several models of inflammation (34), including heart failure (35) and macrophage activation syndrome (MAS) (36), each treated with IL-1β blockade by the IL-1β antagonist anakinra.”
BackgroundSelf-citationNeonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Goldbach-Mansky, R., Dailey, N. J., Canna, S. W., Gelabert, A., Jones, J., Rubin, B. I., Kim, H. J., Brewer, C., Zalewski, C., Wiggs, E., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055137 · Cited by 930
Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome
Lachmann, H. J., Kone-Paut, I., Kuemmerle-Deschner, J. B., Leslie, K. S., Hachulla, E., Quartier, P., Gitton, X., Widmer, A., Patel, N., & Hawkins, P. N. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810787 · Cited by 869
FRET or No FRET: A Quantitative Comparison
Berney, C., & Danuser, G. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)75126-1 · Cited by 652
Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome
Juliana, C., Fernandes-Alnemri, T., Wu, J., Datta, P., Solorzano, L., Yu, J.-W., Meng, R., Quong, A. A., Latz, E., Scott, C. P., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.082305 · Cited by 610
Hoffman, H. M., Throne, M. L., Amar, N. J., Sebai, M., Kivitz, A. J., Kavanaugh, A., Weinstein, S. P., Belomestnov, P., Yancopoulos, G. D., Stahl, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23687 · Cited by 577
Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations
Milner, J. D., Vogel, T. P., Forbes, L., Ma, C. A., Stray-Pedersen, A., Niemela, J. E., Lyons, J. J., Engelhardt, K. R., Zhang, Y., Topcagic, N., et al. (2015) · Blood · doi:10.1182/blood-2014-09-602763 · Cited by 557
Duncan, J. A., Bergstralh, D. T., Wang, Y., Willingham, S. B., Ye, Z., Zimmermann, A. G., & Ting, J. P.-Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611496104 · Cited by 498
The mitochondrial citrate carrier: a new player in inflammation
Infantino, V., Convertini, P., Cucci, L., Panaro, M. A., Di Noia, M. A., Calvello, R., Palmieri, F., & Iacobazzi, V. (2011) · Biochemical Journal · doi:10.1042/bj20111275 · Cited by 385
Salmond, R. J., Filby, A., Qureshi, I., Caserta, S., & Zamoyska, R. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00745.x · Cited by 353
Mechanisms of caspase-1 activation by P2X7 receptor-mediated K+ release
Kahlenberg, J. M., & Dubyak, G. R. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00494.2003 · Cited by 337
Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome
Mazodier, K. (2005) · Blood · doi:10.1182/blood-2005-05-1980 · Cited by 290
He, Y., Varadarajan, S., Muñoz-Planillo, R., Burberry, A., Nakamura, Y., & Núñez, G. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.515080 · Cited by 268
ATP-citrate lyase is essential for macrophage inflammatory response
Infantino, V., Iacobazzi, V., Palmieri, F., & Menga, A. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.037 · Cited by 265
Lluis, J. M., Buricchi, F., Chiarugi, P., Morales, A., & Fernandez-Checa, J. C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0515 · Cited by 221
Inefficient star formation in extremely metal poor galaxies
Shi, Y., Armus, L., Helou, G., Stierwalt, S., Gao, Y., Wang, J., Zhang, Z.-Y., & Gu, Q. (2014) · Nature · doi:10.1038/nature13820 · Cited by 207
Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy
Chae, J. J., Aksentijevich, I., & Kastner, D. L. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07733.x · Cited by 205
Inflammasome and IL-1β-Mediated Disorders
Hoffman, H. M., & Wanderer, A. A. (2010) · Current Allergy and Asthma Reports · doi:10.1007/s11882-010-0109-z · Cited by 168
Neutrophils, IL-1β, and gout: is there a link?
Mitroulis, I., Kambas, K., & Ritis, K. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0361-0 · Cited by 158
Inhibiting the Inflammasome: A Chemical Perspective
Baldwin, A. G., Brough, D., & Freeman, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01091 · Cited by 148
Interleukin-18 mediates interleukin-1-induced cardiac dysfunction
Toldo, S. A., Mezzaroma, E., O’Brien, L. C., Marchetti, C., Seropian, I. M., Voelkel, N. F., Tassell, B. W. V., Dinarello, C. A., & Abbate, A. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00795.2013 · Cited by 141
Self-citationRichter, K., Mathes, V., Fronius, M., Althaus, M., Hecker, A., Krasteva‐Christ, G., Padberg, W. M., Hone, A. J., McIntosh, J. M., Zakrzewicz, A., et al. (2016) · Scientific Reports · doi:10.1038/srep28660 · Cited by 98
Self-citationLee, H. S., Moon, C., Lee, H. W., Park, E., Cho, M.-S., & Kang, J. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.10.7001 · Cited by 90
Intracellular innate immunity in gouty arthritis: role of NALP3 inflammasome
Liu‐Bryan, R. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.93 · Cited by 63
Skeletal muscle glucose metabolism and inflammation in the development of the metabolic syndrome
Marette, A., Liu, Y., & Sweeney, G. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9296-6 · Cited by 63
Factors modulating the inflammatory response in acute gouty arthritis
Cleophas, M. C., Crişan, T. O., & Joosten, L. A. B. (2017) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000366 · Cited by 62
Self-citationSugie, K., Jeon, M., & Grey, H. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406168101 · Cited by 57
The NLRP3 inflammasome, a target for therapy in diverse disease states
Cook, G. P., Savic, S., Wittmann, M., & McDermott, M. (2010) · European Journal of Immunology · doi:10.1002/eji.200940162 · Cited by 53
Glucose metabolism of injured skeletal muscle: the contribution of inflammatory cells.
Shearer, J. D., Amaral, J. F., & Caldwell, M. D. (1988) · PubMed · Cited by 23
Clathrin complexes with the inhibitor kappa B kinase signalosome: imaging the interactome
Gamboni, F., Escobar, G. A., Moore, E. E., Dzieciątkowska, M., Hansen, K. C., Mitra, S., Nydam, T. A., Silliman, C. C., & Banerjee, A. M. (2014) · Physiological Reports · doi:10.14814/phy2.12035 · Cited by 5
Self-citation
Cited by
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884
Targeting the NLRP3 inflammasome in inflammatory diseases
Mangan, M. S. J., Olhava, E. J., Roush, W. R., Seidel, H. M., Glick, G. D., & Latz, E. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.97 · Cited by 1,885
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang, Y., Wang, H., Kouadir, M., Song, H., & Shi, F. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1413-8 · Cited by 1,269
Inflammasome activation and regulation: toward a better understanding of complex mechanisms
Zheng, D., Liwinski, T., & Elinav, E. (2020) · Cell Discovery · doi:10.1038/s41421-020-0167-x · Cited by 1,026
An update on the regulatory mechanisms of NLRP3 inflammasome activation
Paik, S., Kim, J. K., Silwal, P., Sasakawa, C., & Jo, E.-K. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00670-3 · Cited by 892
Metadata
- Authors
- Marchetti, C., Swartzwelter, B., Gamboni, F., Neff, C. P., Richter, K., Azam, T., Carta, S., Tengesdal, I., Nemkov, T., D’Alessandro, A., Henry, C., Jones, G. S., Goodrich, S. A., St. Laurent, J. P., Jones, T. M., Scribner, C. L., Barrow, R. B., Altman, R. D., Skouras, D. B., Gattorno, M., Grau, V., Janciauskiene, S., Rubartelli, A., Joosten, L. A. B., & Dinarello, C. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2018-01-29
- Volume
- 115
- Issue
- 7
- Pages
- E1530-E1539
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2791711864
- Cited by
- 574
- References
- 45
- FWCI
- 13.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.